143 related articles for article (PubMed ID: 11431415)
1. Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to V(alpha)14 NKT cells.
Kamada N; Iijima H; Kimura K; Harada M; Shimizu E; Motohashi Si ; Kawano T; Shinkai H; Nakayama T; Sakai T; Brossay L; Kronenberg M; Taniguchi M
Int Immunol; 2001 Jul; 13(7):853-61. PubMed ID: 11431415
[TBL] [Abstract][Full Text] [Related]
2. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
3. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
Wun KS; Borg NA; Kjer-Nielsen L; Beddoe T; Koh R; Richardson SK; Thakur M; Howell AR; Scott-Browne JP; Gapin L; Godfrey DI; McCluskey J; Rossjohn J
J Exp Med; 2008 Apr; 205(4):939-49. PubMed ID: 18378792
[TBL] [Abstract][Full Text] [Related]
4. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d.
Wu D; Zajonc DM; Fujio M; Sullivan BA; Kinjo Y; Kronenberg M; Wilson IA; Wong CH
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):3972-7. PubMed ID: 16537470
[TBL] [Abstract][Full Text] [Related]
5. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.
Lang GA; Maltsev SD; Besra GS; Lang ML
Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206
[TBL] [Abstract][Full Text] [Related]
6. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.
Kjer-Nielsen L; Borg NA; Pellicci DG; Beddoe T; Kostenko L; Clements CS; Williamson NA; Smyth MJ; Besra GS; Reid HH; Bharadwaj M; Godfrey DI; Rossjohn J; McCluskey J
J Exp Med; 2006 Mar; 203(3):661-73. PubMed ID: 16505140
[TBL] [Abstract][Full Text] [Related]
7. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.
Yu KO; Im JS; Illarionov PA; Ndonye RM; Howell AR; Besra GS; Porcelli SA
J Immunol Methods; 2007 May; 323(1):11-23. PubMed ID: 17442335
[TBL] [Abstract][Full Text] [Related]
9. Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.
Gadola SD; Koch M; Marles-Wright J; Lissin NM; Shepherd D; Matulis G; Harlos K; Villiger PM; Stuart DI; Jakobsen BK; Cerundolo V; Jones EY
J Exp Med; 2006 Mar; 203(3):699-710. PubMed ID: 16520393
[TBL] [Abstract][Full Text] [Related]
10. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand.
Kawano T; Tanaka Y; Shimizu E; Kaneko Y; Kamata N; Sato H; Osada H; Sekiya S; Nakayama T; Taniguchi M
Int Immunol; 1999 Jun; 11(6):881-7. PubMed ID: 10360961
[TBL] [Abstract][Full Text] [Related]
11. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition.
Wei DG; Curran SA; Savage PB; Teyton L; Bendelac A
J Exp Med; 2006 May; 203(5):1197-207. PubMed ID: 16651387
[TBL] [Abstract][Full Text] [Related]
13. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds?
Gumperz JE
Immunol Cell Biol; 2004 Jun; 82(3):285-94. PubMed ID: 15186260
[TBL] [Abstract][Full Text] [Related]
14. BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments.
Lang GA; Illarionov PA; Glatman-Freedman A; Besra GS; Lang ML
Int Immunol; 2005 Jul; 17(7):899-908. PubMed ID: 15967785
[TBL] [Abstract][Full Text] [Related]
15. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
Roy KC; Maricic I; Khurana A; Smith TR; Halder RC; Kumar V
J Immunol; 2008 Mar; 180(5):2942-50. PubMed ID: 18292516
[TBL] [Abstract][Full Text] [Related]
16. A molecular switch in mouse CD1d modulates natural killer T cell activation by α-galactosylsphingamides.
Wang J; Guillaume J; Janssens J; Remesh SG; Ying G; Bitra A; Van Calenbergh S; Zajonc DM
J Biol Chem; 2019 Sep; 294(39):14345-14356. PubMed ID: 31391251
[TBL] [Abstract][Full Text] [Related]
17. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells.
van de Wal Y; Corazza N; Allez M; Mayer LF; Iijima H; Ryan M; Cornwall S; Kaiserlian D; Hershberg R; Koezuka Y; Colgan SP; Blumberg RS
Gastroenterology; 2003 May; 124(5):1420-31. PubMed ID: 12730881
[TBL] [Abstract][Full Text] [Related]
18. Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.
Le Nours J; Praveena T; Pellicci DG; Gherardin NA; Ross FJ; Lim RT; Besra GS; Keshipeddy S; Richardson SK; Howell AR; Gras S; Godfrey DI; Rossjohn J; Uldrich AP
Nat Commun; 2016 Feb; 7():10570. PubMed ID: 26875526
[TBL] [Abstract][Full Text] [Related]
19. The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex.
Sidobre S; Naidenko OV; Sim BC; Gascoigne NR; Garcia KC; Kronenberg M
J Immunol; 2002 Aug; 169(3):1340-8. PubMed ID: 12133957
[TBL] [Abstract][Full Text] [Related]
20. Regulation of immune responses by CD1d-restricted natural killer T cells.
Van Kaer L
Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
